• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).

出版信息

Pediatr Int. 2014 Apr;56(2):135-58. doi: 10.1111/ped.12317.

DOI:10.1111/ped.12317
PMID:24730626
Abstract
摘要

相似文献

1
Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).急性川崎病的医学治疗指南：日本小儿心脏病学会和心脏外科学会研究委员会报告（2012年修订版）
Pediatr Int. 2014 Apr;56(2):135-58. doi: 10.1111/ped.12317.
2
Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.一名幼儿的不完全性和非典型川崎病：对英夫利昔单抗有反应的严重、难治性疾病。
Clin Pediatr (Phila). 2007 May;46(4):345-8. doi: 10.1177/0009922806294842.
3
Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.口服泼尼松龙和阿司匹林治疗重症复杂型川崎病
J Pediatr. 2000 Nov;137(5):723-6. doi: 10.1067/mpd.2000.108444.
4
[Improving the diagnosis and therapy of Kawasaki disease].[改善川崎病的诊断与治疗]
Zhonghua Er Ke Za Zhi. 2006 May;44(5):321-3.
5
Infantile Kawasaki disease and peripheral gangrene.小儿川崎病与周围坏疽
J Pediatr. 2006 Jul;149(1):131-3. doi: 10.1016/j.jpeds.2006.02.043.
6
Response of refractory Kawasaki disease to intravenous methylprednisolone.难治性川崎病对静脉注射甲泼尼龙的反应。
Ann Trop Paediatr. 2009 Mar;29(1):51-3. doi: 10.1179/146532809X402033.
7
Is there a role for corticosteroids in Kawasaki disease?皮质类固醇在川崎病中起作用吗？
J Pediatr. 2003 Jun;142(6):601-3. doi: 10.1067/mpd.2003.258.
8
Should infliximab be used as an adjuvant to IVIG in the treatment of children with Kawasaki disease who are at high risk for resistance to conventional therapy?英夫利昔单抗是否应用于对传统治疗耐药风险高的川崎病患儿，作为静脉注射免疫球蛋白的辅助治疗？
Pediatr Cardiol. 2013 Oct;34(7):1756. doi: 10.1007/s00246-013-0731-3. Epub 2013 Jun 15.
9
[Reply to questions regarding diagnosis and treatment of Kawasaki disease].[关于川崎病诊断与治疗问题的回复]
Zhonghua Er Ke Za Zhi. 2006 May;44(5):337-8.
10
Treatment of Kawasaki disease.川崎病的治疗
N Engl J Med. 2007 Jun 28;356(26):2747; author reply 2748.

引用本文的文献

1
Limited Performance of Machine Learning Models Developed Based on Demographic and Laboratory Data Obtained Before Primary Treatment to Predict Coronary Aneurysms.基于初次治疗前获得的人口统计学和实验室数据开发的机器学习模型预测冠状动脉瘤的性能有限。
Biomedicines. 2025 Apr 29;13(5):1073. doi: 10.3390/biomedicines13051073.
2
Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study.10%与5%免疫球蛋白产品对川崎病治疗结局的影响：一项多中心回顾性研究
Sci Rep. 2025 May 27;15(1):18502. doi: 10.1038/s41598-025-03395-9.
3
Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study.
静脉注射免疫球蛋白辅助治疗英夫利昔单抗难治性川崎病的效果：一项队列研究
Pediatr Rheumatol Online J. 2025 May 13;23(1):49. doi: 10.1186/s12969-025-01108-0.
4
Serum salicylic acid levels in children with Kawasaki disease.川崎病患儿血清水杨酸水平。
BMC Pediatr. 2024 Sep 28;24(1):613. doi: 10.1186/s12887-024-05100-7.
5
Jaundice-predominant manifestation of Kawasaki disease in children.黄疸是儿童川崎病的主要表现。
Front Pediatr. 2024 Jan 9;11:1281909. doi: 10.3389/fped.2023.1281909. eCollection 2023.
6
Initial intravenous immunoglobulin therapy without aspirin for acute Kawasaki disease: a retrospective cohort study with a Bayesian inference.急性川崎病初始静脉注射免疫球蛋白治疗而不使用阿司匹林：一项基于贝叶斯推断的回顾性队列研究。
BMJ Paediatr Open. 2024 Jan 17;8(1):e002312. doi: 10.1136/bmjpo-2023-002312.
7
[Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].《中国儿童川崎病诊断与治疗循证指南（2023年版）》
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1198-1210. doi: 10.7499/j.issn.1008-8830.2309038.
8
DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease.川崎病后巨大冠状动脉瘤患者的直接口服抗凝剂
JAMA Netw Open. 2023 Nov 1;6(11):e2343801. doi: 10.1001/jamanetworkopen.2023.43801.
9
Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review.目前关于 TNF-α 单克隆抗体英夫利昔单抗治疗川崎病的知识：全面综述。
Front Immunol. 2023 Oct 23;14:1237670. doi: 10.3389/fimmu.2023.1237670. eCollection 2023.
10
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.冠状动脉瘤严重程度对川崎病患者冠状动脉瘤消退的影响分析：消退相关因素。
J Am Heart Assoc. 2023 Feb 7;12(3):e022417. doi: 10.1161/JAHA.121.022417. Epub 2023 Jan 31.